Skip to main content

USANA HEALTH SCIENCES INC

For the period ended Sep 28, 2024. Filed Nov 5, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 28, 2024 · Filed Nov 5, 2024

USNA$13.10-5.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Comprehensive Income

Three Months EndedNine Months Ended
September 28,2024September 30,2023September 28,2024September 30,2023
Net sales$200,221$213,365$640,890$699,927
Cost of sales39,25742,529122,659134,374
Gross profit160,964170,836518,231565,553
Operating expenses:
Associate incentives84,06889,926270,197298,376
Selling, general and administrative61,29563,303189,920198,325
Total operating expenses145,363153,229460,117496,701
Earnings from operations15,60117,60758,11468,852
Other income (expense):
Interest income3,1422,7338,5816,732
Interest expense(49)(43)(152)(117)
Other, net(86)234(621)375
Other income (expense), net3,0072,9247,8086,990
Earnings before income taxes18,60820,53165,92275,842
Income taxes8,0019,18428,34628,820
Net earnings$10,607$11,347$37,576$47,022
Earnings per common share
Basic$0.56$0.59$1.97$2.44
Diluted$0.56$0.59$1.96$2.43
Weighted average common shares outstanding
Basic19,07819,24519,10819,283
Diluted19,08319,37219,18119,376
Comprehensive income:
Net earnings$10,607$11,347$37,576$47,022
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment7,654(1,933)706(8,236)
Tax benefit (expense) related to foreign currency translation adjustment(845)185(710)799
Other comprehensive income (loss), net of tax6,809(1,748)(4)(7,437)
Comprehensive income$17,416$9,599$37,572$39,585
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.